BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8476748)

  • 1. Structure-function studies of human aromatase.
    Chen S; Zhou D; Swiderek KM; Kadohama N; Osawa Y; Hall PF
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):347-56. PubMed ID: 8476748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis.
    Graham-Lorence S; Khalil MW; Lorence MC; Mendelson CR; Simpson ER
    J Biol Chem; 1991 Jun; 266(18):11939-46. PubMed ID: 2050688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of seven inhibitors of human aromatase: a site-directed mutagenesis study.
    Kao YC; Cam LL; Laughton CA; Zhou D; Chen S
    Cancer Res; 1996 Aug; 56(15):3451-60. PubMed ID: 8758911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A detailed molecular model for human aromatase.
    Laughton CA; Zvelebil MJ; Neidle S
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):399-407. PubMed ID: 8476753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments.
    Chen S; Zhou D
    J Biol Chem; 1992 Nov; 267(31):22587-94. PubMed ID: 1429608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for the interaction of four different classes of substrates and inhibitors with human aromatase.
    Hong Y; Cho M; Yuan YC; Chen S
    Biochem Pharmacol; 2008 Mar; 75(5):1161-9. PubMed ID: 18184606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis.
    Amarneh B; Corbin CJ; Peterson JA; Simpson ER; Graham-Lorence S
    Mol Endocrinol; 1993 Dec; 7(12):1617-24. PubMed ID: 8145767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase.
    Chen S; Kao YC; Laughton CA
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):107-15. PubMed ID: 9365179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A site-directed mutagenesis study of human placental aromatase.
    Zhou DJ; Korzekwa KR; Poulos T; Chen SA
    J Biol Chem; 1992 Jan; 267(2):762-8. PubMed ID: 1730667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450.
    Zhou D; Cam LL; Laughton CA; Korzekwa KR; Chen S
    J Biol Chem; 1994 Jul; 269(30):19501-8. PubMed ID: 8034720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study.
    Kao YC; Zhou C; Sherman M; Laughton CA; Chen S
    Environ Health Perspect; 1998 Feb; 106(2):85-92. PubMed ID: 9435150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308----Phe, Tyr-361----Phe, Tyr-361----Leu, and Phe-406----Arg.
    Zhou DJ; Pompon D; Chen SA
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):410-4. PubMed ID: 1988941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase.
    Hong Y; Yu B; Sherman M; Yuan YC; Zhou D; Chen S
    Mol Endocrinol; 2007 Feb; 21(2):401-14. PubMed ID: 17095574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic efficiency of expressed aromatase following site-directed mutagenesis.
    Kadohama N; Zhou D; Chen S; Osawa Y
    Biochim Biophys Acta; 1993 May; 1163(2):195-200. PubMed ID: 8490051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the mechanism of aromatase cytochrome P450. A site-directed mutagenesis study.
    Kao YC; Korzekwa KR; Laughton CA; Chen S
    Eur J Biochem; 2001 Jan; 268(2):243-51. PubMed ID: 11168357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of substrate specificity of human aromatase by site directed mutagenesis.
    Auvray P; Nativelle C; Bureau R; Dallemagne P; Séralini GE; Sourdaine P
    Eur J Biochem; 2002 Mar; 269(5):1393-405. PubMed ID: 11874453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH).
    Okubo T; Truong TK; Yu B; Itoh T; Zhao J; Grube B; Zhou D; Chen S
    Cancer Res; 2001 Feb; 61(4):1338-46. PubMed ID: 11245431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a complementary deoxyribonucleic acid insert encoding bovine aromatase cytochrome P450.
    Hinshelwood MM; Corbin CJ; Tsang PC; Simpson ER
    Endocrinology; 1993 Nov; 133(5):1971-7. PubMed ID: 8404644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase activity induction in human adipose fibroblasts by retinoic acids via retinoic acid receptor α.
    Wilde J; Erdmann M; Mertens M; Eiselt G; Schmidt M
    J Mol Endocrinol; 2013 Oct; 51(2):247-60. PubMed ID: 24023268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors: past, present and future.
    Séralini G; Moslemi S
    Mol Cell Endocrinol; 2001 Jun; 178(1-2):117-31. PubMed ID: 11403901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.